SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months The Medical News, 22 Oct 2021 As the coronavirus disease 2019 (COVID-19) pandemic continues to take a heavy toll on the world population, scientists are…